Scholarlink

Purpose <p>This study assesses the feasibility of single-step vitrification and warming (SSV/SSW) for human blastocysts. Previous animal study models have shown possibilities of shorter cryopreservation methodologies by cryoprotectant and temperature adjustments. The main research question investigates whether SSV/SSW can serve as an effective alternative to stepwise vitrification (SWV) and warming procedures, ensuring comparable embryological and clinical outcomes.</p> Method <p>The study was conducted at a single center. Validation of SSV combined with SSW assessing survival, re-expansion, and development after 24&#xa0;h was performed using research blastocysts. Cryoprotectant (CPA) levels were measured in three different SSW sucrose solutions after SSV or SWV. We introduced the valid method in the clinic and report laboratory and clinical outcomes of 333 SWV/SSW against 568 SSV/SSW blastocyst transfers.</p> Results <p>During validation, SSV at 37&#xa0;°C, compared to SWV, combined with 1&#xa0;M sucrose SSW demonstrated comparable collapsing (89.6% vs. 98.1%) and re-expansion outcomes (97.9% vs. 88.7%). Extracellular CPA analysis (79.3&#xa0;mg/L vs. 127.3&#xa0;mg/L; <i>p</i> &lt; 0.001) indicated significantly lower intracellular uptake following SSV compared to SWV. Clinical data showed significantly lower rates of collapsing (67.8% vs. 92.5%, <i>p</i> &lt; 0.001) and re-expansion (72.0% vs. 89.5%, <i>p</i> &lt; 0.001) after SSV compared to SWV, but similar rates of ongoing pregnancy (25.9% vs. 26.1%) and secondary clinical outcomes.</p> Conclusion <p>SSV combined with SSW is a feasible, operationally efficient alternative to SWV and warming procedures open to further optimize the collapse status before or during vitrification. The method reduces handling time, CPA exposure, and operator-related errors while maintaining ongoing pregnancy rates.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Validation and clinical study of single-step vitrification combined with single-step warming of human blastocysts

  • 期刊论文

  • 发表日期：

    2026年2月13日

查看全文
  • Jan Gunst,
  • Hubert Joris,
  • Matthijs Vynck,
  • Kristof Godderis,
  • Martine Vercammen,
  • Sylvie Roggeman,
  • Arne van de Vijver

摘要

Purpose

This study assesses the feasibility of single-step vitrification and warming (SSV/SSW) for human blastocysts. Previous animal study models have shown possibilities of shorter cryopreservation methodologies by cryoprotectant and temperature adjustments. The main research question investigates whether SSV/SSW can serve as an effective alternative to stepwise vitrification (SWV) and warming procedures, ensuring comparable embryological and clinical outcomes.

Method

The study was conducted at a single center. Validation of SSV combined with SSW assessing survival, re-expansion, and development after 24 h was performed using research blastocysts. Cryoprotectant (CPA) levels were measured in three different SSW sucrose solutions after SSV or SWV. We introduced the valid method in the clinic and report laboratory and clinical outcomes of 333 SWV/SSW against 568 SSV/SSW blastocyst transfers.

Results

During validation, SSV at 37 °C, compared to SWV, combined with 1 M sucrose SSW demonstrated comparable collapsing (89.6% vs. 98.1%) and re-expansion outcomes (97.9% vs. 88.7%). Extracellular CPA analysis (79.3 mg/L vs. 127.3 mg/L; p < 0.001) indicated significantly lower intracellular uptake following SSV compared to SWV. Clinical data showed significantly lower rates of collapsing (67.8% vs. 92.5%, p < 0.001) and re-expansion (72.0% vs. 89.5%, p < 0.001) after SSV compared to SWV, but similar rates of ongoing pregnancy (25.9% vs. 26.1%) and secondary clinical outcomes.

Conclusion

SSV combined with SSW is a feasible, operationally efficient alternative to SWV and warming procedures open to further optimize the collapse status before or during vitrification. The method reduces handling time, CPA exposure, and operator-related errors while maintaining ongoing pregnancy rates.